NCT01120873View on ClinicalTrials.gov

The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome

PHASE3CompletedINTERVENTIONAL

Enrollment

110

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions

Metabolic Syndrome

Interventions

DRUG

Metamin 3D

Metamin 3D is composed by red yeast rice, bitter gourd, chlorella, soy peptide and licorice extract is a commercial product designed by Uni-President enterprises corp in Taiwan

Trial Locations (1)

407

Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichang

All Listed Sponsors

lead

Taichung Veterans General Hospital

OTHER

NCT01120873 - The Effect of Metamin 3D on the Lipid and Glucose in Subjects With Metabolic Syndrome | Biotech Hunter | Biotech Hunter